GEN-001 Plus Pembrolizumab for Patients With Advanced Refractory Biliary Tract Cancer

NCT05998447 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Biliary Tract Cancer

Interventions

DRUG: GEN-001
DRUG: Pembrolizumab
DRUG: mFOLFOX

Sponsor

Genome & Company

Collaborators

[object Object]